Preventing Infection in the Intensive Care Unit (ICU): The Role of Medication Management and Use (MMU)

Abstract

Healthcare-associated infections (HAIs) remain a major cause of morbidity, mortality, prolonged hospitalization, and increased healthcare costs in Intensive Care Units (ICUs). Critically ill patients are particularly vulnerable due to invasive procedures, immunosuppression, prolonged antibiotic exposure, and complex medication regimens. Effective Medication Management and Use (MMU) systems play a pivotal role in preventing ICU-acquired infections by ensuring safe, appropriate, and evidence-based use of antimicrobial and supportive medications. This paper explores the role of MMU in infection prevention in the ICU, highlighting antimicrobial stewardship, medication safety, interdisciplinary collaboration, and adherence to international standards. Practical strategies, challenges, and measurable outcomes are discussed.